Company Filing History:
3 out of 3,580 
1 out of 832,880 Years Active: 1979-1987
Title: Martin R Damiani: Innovator in Tumor Treatment and Immune Modulation
Introduction
Martin R Damiani is a notable inventor based in Allendale, NJ (US), recognized for his contributions to the field of medical treatments, particularly in the area of tumor regression and immune response modulation. With a total of four patents to his name, Damiani has made significant strides in developing methods that enhance the immune system and treat transplanted tumors in warm-blooded animals.
Latest Patents
Among his latest patents, one notable invention is a method of treating transplanted tumors and modulating the immune response. This patent describes compositions of matter that are useful for inducing the regression of transplanted tumors in warm-blooded animals. The active ingredients in these compositions include 3,6-bis[2-(1-piperidino)ethoxy]acridine or its pharmacologically acceptable acid-addition salts. Another significant patent involves certain 3,6-bis-(heteroaminoalkoxy) acridines, which also focus on inducing tumor regression and enhancing the immune system in mammals.
Career Highlights
Throughout his career, Martin R Damiani has worked with prominent organizations, including the American Cyanamid Company. His work has been pivotal in advancing medical treatments that address critical health challenges related to tumors and immune responses.
Collaborations
Damiani has collaborated with esteemed colleagues such as Frederick E Durr and Keith C Murdock, contributing to the development of innovative solutions in his field.
Conclusion
Martin R Damiani's work exemplifies the impact of innovation in medical science, particularly in the treatment of tumors and the enhancement of immune responses. His patents reflect a commitment to improving health outcomes through scientific advancement.